US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist

15.762
+0.572+3.77%

Trading Dec 2 11:52 ET

26.15MMarket Cap-2557P/E (TTM)

Cadrenal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

115.30%2.46M

140.37%2.47M

-58.20%1.76M

7.63M

1.26M

17.46%1.14M

112.75%1.03M

2,363.18%4.2M

972.79K

482.35K

Selling and administrative expenses

86.50%1.67M

54.52%1.21M

16.72%1.13M

--3.55M

--902.11K

-1.95%898.05K

180.11%784.62K

531.94%964.73K

--915.9K

--280.11K

-General and administrative expense

86.50%1.67M

54.52%1.21M

16.72%1.13M

--3.55M

--902.11K

-1.95%898.05K

180.11%784.62K

531.94%964.73K

--915.9K

--280.11K

Research and development costs

221.64%784.65K

420.30%1.25M

-80.56%629.03K

--4.08M

--361.13K

332.62%243.95K

19.15%240.96K

18,014.88%3.24M

--56.39K

--202.24K

Depreciation amortization depletion

-31.83%407

-21.27%470

214.21%597

--1.98K

--597

17.98%597

--597

--190

--506

--0

-Depreciation and amortization

-31.83%407

-21.27%470

214.21%597

--1.98K

--597

17.98%597

--597

--190

--506

--0

Operating profit

-115.30%-2.46M

-140.37%-2.47M

58.20%-1.76M

-7.63M

-1.26M

-17.46%-1.14M

-112.75%-1.03M

-2,363.18%-4.2M

-972.79K

-482.35K

Net non-operating interest income expense

-50.89%52.13K

217.73%73.64K

639.89%92.33K

231.99K

119.77K

431.59%106.15K

256.91%23.18K

-272.65%-17.1K

-32.01K

-14.77K

Non-operating interest income

-50.89%52.13K

217.73%73.64K

--92.33K

--249.09K

--119.77K

3,538,066.67%106.15K

--23.18K

--0

--3

--0

Non-operating interest expense

--0

--17.1K

--0

272.65%17.1K

--32.01K

--14.77K

Other net income (expense)

-956.23K

-62,073.86%-956.23K

-21.31K

-5.02K

Gain on sale of security

----

---216.1K

--0

----

-13,950.39%-216.1K

---21.31K

---5.02K

Special income (charges)

--0

---740.14K

--0

---740.14K

--0

-Less:Other special charges

----

--740.14K

--0

----

--740.14K

----

Income before tax

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

-8.36M

-1.14M

-1.01%-1.04M

-99.74%-1M

-2,828.75%-5.17M

-1.03M

-502.14K

Income tax

Net income

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

-8.36M

-1.14M

-1.01%-1.04M

-99.74%-1M

-2,828.75%-5.17M

-1.03M

-502.14K

Net income continuous Operations

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

---8.36M

---1.14M

-1.01%-1.04M

-99.74%-1M

-2,828.75%-5.17M

---1.03M

---502.14K

Minority interest income

Net income attributable to the parent company

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

-8.36M

-1.14M

-1.01%-1.04M

-99.74%-1M

-2,828.75%-5.17M

-1.03M

-502.14K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

-8.36M

-1.14M

-1.01%-1.04M

-99.74%-1M

-2,828.75%-5.17M

-1.03M

-502.14K

Basic earnings per share

-115.84%-2.18

-66.67%-2.25

79.17%-1.5

-9.3

-0.74

23.65%-1.01

-108.53%-1.35

-3,061.43%-7.2

-1.3229

-0.6474

Diluted earnings per share

-115.84%-2.18

-66.67%-2.25

79.17%-1.5

-9.3

-0.74

23.65%-1.01

-108.53%-1.35

-3,061.43%-7.2

-1.3229

-0.6474

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	115.30%2.46M	140.37%2.47M	-58.20%1.76M	7.63M	1.26M	17.46%1.14M	112.75%1.03M	2,363.18%4.2M	972.79K	482.35K
Selling and administrative expenses	86.50%1.67M	54.52%1.21M	16.72%1.13M	--3.55M	--902.11K	-1.95%898.05K	180.11%784.62K	531.94%964.73K	--915.9K	--280.11K
-General and administrative expense	86.50%1.67M	54.52%1.21M	16.72%1.13M	--3.55M	--902.11K	-1.95%898.05K	180.11%784.62K	531.94%964.73K	--915.9K	--280.11K
Research and development costs	221.64%784.65K	420.30%1.25M	-80.56%629.03K	--4.08M	--361.13K	332.62%243.95K	19.15%240.96K	18,014.88%3.24M	--56.39K	--202.24K
Depreciation amortization depletion	-31.83%407	-21.27%470	214.21%597	--1.98K	--597	17.98%597	--597	--190	--506	--0
-Depreciation and amortization	-31.83%407	-21.27%470	214.21%597	--1.98K	--597	17.98%597	--597	--190	--506	--0
Operating profit	-115.30%-2.46M	-140.37%-2.47M	58.20%-1.76M	-7.63M	-1.26M	-17.46%-1.14M	-112.75%-1.03M	-2,363.18%-4.2M	-972.79K	-482.35K
Net non-operating interest income expense	-50.89%52.13K	217.73%73.64K	639.89%92.33K	231.99K	119.77K	431.59%106.15K	256.91%23.18K	-272.65%-17.1K	-32.01K	-14.77K
Non-operating interest income	-50.89%52.13K	217.73%73.64K	--92.33K	--249.09K	--119.77K	3,538,066.67%106.15K	--23.18K	--0	--3	--0
Non-operating interest expense	--0	--0	--0	--17.1K	--0	--0	--0	272.65%17.1K	--32.01K	--14.77K
Other net income (expense)				-956.23K	0			-62,073.86%-956.23K	-21.31K	-5.02K
Gain on sale of security	----	----	----	---216.1K	--0	----	----	-13,950.39%-216.1K	---21.31K	---5.02K
Special income (charges)	--0	--0	--0	---740.14K	--0	--0	--0	---740.14K	--0	--0
-Less:Other special charges	----	----	----	--740.14K	--0	----	----	--740.14K	----	----
Income before tax	-132.31%-2.41M	-138.58%-2.39M	67.85%-1.66M	-8.36M	-1.14M	-1.01%-1.04M	-99.74%-1M	-2,828.75%-5.17M	-1.03M	-502.14K
Income tax
Net income	-132.31%-2.41M	-138.58%-2.39M	67.85%-1.66M	-8.36M	-1.14M	-1.01%-1.04M	-99.74%-1M	-2,828.75%-5.17M	-1.03M	-502.14K
Net income continuous Operations	-132.31%-2.41M	-138.58%-2.39M	67.85%-1.66M	---8.36M	---1.14M	-1.01%-1.04M	-99.74%-1M	-2,828.75%-5.17M	---1.03M	---502.14K
Minority interest income
Net income attributable to the parent company	-132.31%-2.41M	-138.58%-2.39M	67.85%-1.66M	-8.36M	-1.14M	-1.01%-1.04M	-99.74%-1M	-2,828.75%-5.17M	-1.03M	-502.14K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-132.31%-2.41M	-138.58%-2.39M	67.85%-1.66M	-8.36M	-1.14M	-1.01%-1.04M	-99.74%-1M	-2,828.75%-5.17M	-1.03M	-502.14K
Basic earnings per share	-115.84%-2.18	-66.67%-2.25	79.17%-1.5	-9.3	-0.74	23.65%-1.01	-108.53%-1.35	-3,061.43%-7.2	-1.3229	-0.6474
Diluted earnings per share	-115.84%-2.18	-66.67%-2.25	79.17%-1.5	-9.3	-0.74	23.65%-1.01	-108.53%-1.35	-3,061.43%-7.2	-1.3229	-0.6474
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data